Blog

Contact Us
August 13, 2024

Understanding ovarian cancer and how the ROCA Test helps to manage your risk.

Ovarian cancer is a formidable cancer and long-term outcomes remain poor. While we have an increasing number of diagnostic tools, surgical methods and treatments to prevent, diagnose and treat ovarian cancer, we still need to do more.
August 2, 2024

The NICE Guidelines: A Layman’s Guide

On March 21, 2024, the National Institute for Health and Care Excellence (NICE) released new guidelines to help the NHS identify and support individuals at high risk for ovarian cancer. Here’s a breakdown of what you need to know:
May 30, 2023 Keyboard-for-Blogs-Section-scaled

An increase in early-stage ovarian cancer detected in women using the ROCA test.

In November 2022, the Journal of Medical Genetics published a paper that presented the results of a pilot national ovarian cancer surveillance programme using the ROCA Test, for women with alterations in the BRCA1 and BRCA2 genes.
May 11, 2023 shutterstock_1722358774

Ovarian Cancer Surveillance using the ROCA Test: The Evidence Explained

In November 2022, the Journal of Medical Genetics published a paper that presents the results of a pilot national surveillance programme using the ROCA Test, for women with alterations in the BRCA1 and BRCA2 genes. The study was called ALDO, meaning ‘Avoiding Late Diagnosis of Ovarian cancer’.